Skip to main content

Chemistry

Disease Correlation

Understanding how lipid tests connect to specific disease states is vital for effective diagnosis and management. Lipids, including cholesterol and triglycerides, play a critical role in various physiological processes. Abnormal lipid levels are associated with several disease states * Key Conditions * Atherosclerosis * Coronary Artery Disease (CAD) * Hyperlipidemia and Dyslipidemia * Metabolic Syndrome * Acute Pancreatitis * Lipoprotein Disorders (e.g., Familial Hypercholesterolemia, Tangier Disease) * Non-Alcoholic Fatty Liver Disease (NAFLD)

Atherosclerosis

  • Definition: A chronic inflammatory disease characterized by the accumulation of lipids, cholesterol, calcium, and cellular debris within the walls of arteries, leading to plaque formation and narrowing of the arterial lumen
  • Laboratory Findings
    • Elevated LDL Cholesterol (LDL-C): > 130 mg/dL (3.37 mmol/L)
    • Elevated Non-HDL Cholesterol: > 160 mg/dL (4.14 mmol/L)
    • Elevated Apolipoprotein B (Apo B): > 130 mg/dL
    • Low HDL Cholesterol (HDL-C): < 40 mg/dL (1.0 mmol/L)
    • Elevated Lipoprotein (a) [Lp(a)]: > 30 mg/dL or > 75 nmol/L
  • Disease State Correlation
    • Elevated LDL-C and non-HDL-C contribute to lipid accumulation in the arterial wall
    • Low HDL-C impairs reverse cholesterol transport, reducing the removal of cholesterol from the arterial wall
    • Elevated Apo B indicates an increased number of atherogenic particles
    • Elevated Lp(a) promotes thrombosis and inflammation
  • Clinical Significance
    • Atherosclerosis is the underlying cause of most cardiovascular diseases
    • Early detection and management of risk factors are essential to prevent or slow disease progression

Coronary Artery Disease (CAD)

  • Definition: A condition characterized by the narrowing or blockage of the coronary arteries, usually due to atherosclerosis, leading to reduced blood flow to the heart muscle
  • Laboratory Findings
    • Elevated LDL Cholesterol (LDL-C): > 100 mg/dL (2.59 mmol/L)
    • Elevated Non-HDL Cholesterol: > 130 mg/dL (3.37 mmol/L)
    • Low HDL Cholesterol (HDL-C): < 40 mg/dL (1.0 mmol/L)
    • Elevated Triglycerides: > 150 mg/dL (1.7 mmol/L)
    • Elevated Lipoprotein (a) [Lp(a)]: > 30 mg/dL or > 75 nmol/L
  • Disease State Correlation
    • Abnormal lipid levels contribute to plaque formation and narrowing of the coronary arteries
    • Elevated Lp(a) increases the risk of thrombosis and acute coronary events
  • Clinical Significance
    • CAD can lead to angina, myocardial infarction (heart attack), heart failure, and sudden cardiac death
    • Management involves lifestyle modifications, medications (statins, antiplatelet agents), and procedures (angioplasty, bypass surgery)

Hyperlipidemia and Dyslipidemia

  • Definitions
    • Hyperlipidemia: Elevated levels of lipids (fats) in the blood
    • Dyslipidemia: Abnormal lipid profile, including high LDL cholesterol, low HDL cholesterol, and/or high triglycerides
  • Laboratory Findings
    • Elevated Total Cholesterol (TC): > 200 mg/dL (5.18 mmol/L)
    • Elevated LDL Cholesterol (LDL-C): > 130 mg/dL (3.37 mmol/L)
    • Elevated Triglycerides (TG): > 150 mg/dL (1.7 mmol/L)
    • Low HDL Cholesterol (HDL-C): < 40 mg/dL (1.0 mmol/L)
  • Disease State Correlation
    • These conditions increase the risk of atherosclerosis, CAD, stroke, and peripheral artery disease
  • Clinical Significance
    • Management involves lifestyle modifications (diet, exercise) and medications (statins, fibrates, niacin, omega-3 fatty acids)
    • Early detection and treatment are essential to prevent cardiovascular complications

Metabolic Syndrome

  • Definition: A cluster of conditions that occur together, increasing the risk of heart disease, stroke, and type 2 diabetes
  • Diagnostic Criteria (ATP III Guidelines)
    • Three or more of the following:
      • Abdominal Obesity: Waist circumference > 40 inches (102 cm) in men or > 35 inches (88 cm) in women
      • Elevated Triglycerides: > 150 mg/dL (1.7 mmol/L)
      • Low HDL Cholesterol: < 40 mg/dL (1.0 mmol/L) in men or < 50 mg/dL (1.3 mmol/L) in women
      • Elevated Blood Pressure: ≥ 130/85 mmHg
      • Elevated Fasting Glucose: ≥ 100 mg/dL (5.6 mmol/L)
  • Laboratory Findings
    • Elevated Triglycerides: > 150 mg/dL (1.7 mmol/L)
    • Low HDL Cholesterol: < 40 mg/dL (1.0 mmol/L) in men or < 50 mg/dL (1.3 mmol/L) in women
    • Elevated Fasting Glucose: ≥ 100 mg/dL (5.6 mmol/L)
  • Disease State Correlation
    • Metabolic syndrome increases the risk of cardiovascular disease, type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), and certain cancers
  • Clinical Significance
    • Management involves lifestyle modifications (diet, exercise, weight loss) and medications to address individual components of the syndrome

Acute Pancreatitis

  • Definition: Inflammation of the pancreas, which can be caused by gallstones, alcohol abuse, medications, or hypertriglyceridemia
  • Laboratory Findings
    • Elevated Triglycerides: > 500 mg/dL (5.7 mmol/L)
    • Elevated Amylase and Lipase: Enzymes released from the damaged pancreas
  • Disease State Correlation
    • Hypertriglyceridemia can cause pancreatic damage due to the formation of toxic free fatty acids
  • Clinical Significance
    • Management involves supportive care, including intravenous fluids, pain management, and bowel rest
    • In severe cases, treatment may include plasma exchange (apheresis) to rapidly lower triglyceride levels

Lipoprotein Disorders

  • Definition: Genetic disorders that affect lipoprotein synthesis, structure, or metabolism, leading to abnormal lipid levels
  • Examples
    • Familial Hypercholesterolemia (FH)
      • Elevated LDL Cholesterol (LDL-C): > 190 mg/dL (4.91 mmol/L) in adults or > 160 mg/dL (4.14 mmol/L) in children
      • Genetic testing reveals mutations in the LDL receptor gene, ApoB gene, or PCSK9 gene
    • Familial Hypertriglyceridemia (FHTG)
      • Elevated Triglycerides: > 200 mg/dL (2.26 mmol/L)
      • Genetic testing may reveal mutations in genes involved in triglyceride metabolism (e.g., LPL, ApoC2)
    • Tangier Disease
      • Very Low HDL Cholesterol (HDL-C): < 5 mg/dL (0.13 mmol/L)
      • Genetic testing reveals mutations in the ABCA1 gene
  • Disease State Correlation
    • FH increases the risk of premature cardiovascular disease
    • FHTG increases the risk of pancreatitis and cardiovascular disease
    • Tangier disease is associated with enlarged orange tonsils, neuropathy, and premature cardiovascular disease
  • Clinical Significance
    • Early diagnosis and management are essential to prevent complications
    • Treatment involves lifestyle modifications, medications, and sometimes specialized therapies

Non-Alcoholic Fatty Liver Disease (NAFLD)

  • Definition: A condition characterized by the accumulation of excess fat in the liver in individuals who do not consume excessive alcohol
  • Laboratory Findings
    • Elevated Liver Enzymes: ALT and AST (indicators of liver inflammation/damage)
    • Elevated Triglycerides: > 150 mg/dL (1.7 mmol/L)
    • Elevated Fasting Glucose: ≥ 100 mg/dL (5.6 mmol/L)
    • Elevated LDL Cholesterol (LDL-C): > 130 mg/dL (3.37 mmol/L)
    • Low HDL Cholesterol (HDL-C): < 40 mg/dL (1.0 mmol/L) in men or < 50 mg/dL (1.3 mmol/L) in women
  • Disease State Correlation
    • NAFLD is associated with insulin resistance, obesity, metabolic syndrome, and an increased risk of cardiovascular disease
    • Non-Alcoholic Steatohepatitis (NASH): A more severe form of NAFLD characterized by inflammation and liver damage
  • Clinical Significance
    • Management involves lifestyle modifications (weight loss, diet, exercise) and medications to address underlying conditions

Key Terms

  • Atherosclerosis: Plaque buildup in arteries
  • Coronary Artery Disease (CAD): Narrowing or blockage of the coronary arteries
  • Hyperlipidemia: Elevated levels of lipids in the blood
  • Dyslipidemia: Abnormal lipid profile
  • Metabolic Syndrome: A cluster of conditions that increase the risk of heart disease, stroke, and diabetes
  • Acute Pancreatitis: Inflammation of the pancreas
  • Familial Hypercholesterolemia (FH): A genetic disorder characterized by high LDL-C levels
  • Familial Hypertriglyceridemia (FHTG): A genetic disorder characterized by elevated triglyceride levels
  • Tangier Disease: A genetic disorder characterized by very low HDL-C levels
  • Non-Alcoholic Fatty Liver Disease (NAFLD): Excess fat accumulation in the liver not caused by excessive alcohol consumption
  • Lipoproteins: Particles that transport lipids in the blood